Skip to search.
 FTSE 100 Down 0.58%

More On UCBJY

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

UCB S.A. (UCBJY)

-Other OTC
37.45 Up 0.49(1.33%) 27 Mar 18:50
Add to Portfolio
Prev Close:36.96
Open:37.45
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:37.45 - 37.45
52wk Range:34.92 - 49.29
Volume:111
Avg Vol (3m):821
Market Cap:14.57b
P/E (ttm):64.18
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for UCBJY at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

UCB S.A., a biopharmaceutical company, focuses on various diseases in therapeutic areas of neurology and immunology in Belgium and internationally. The company’s products include Cimzia for Crohn’s disease, rheumatoid arthritis, psoriati... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback